https://curecalpain3.org/welcome/2017-04-27T20:23:13+00:00https://curecalpain3.org/c3-lends-support-to-new-initiative-in-genetic-testing-for-lgmd2a-patients/2017-04-27T19:30:45+00:00https://curecalpain3.org/c3-supports-generation-of-new-lgmd2a-disease-model-for-research/2017-05-02T17:37:27+00:00https://curecalpain3.org/coalition-to-cure-calpain-3-announces-conclusion-of-current-request-for-application/2017-05-05T13:03:09+00:00https://curecalpain3.org/c3-awards-grant-to-dr-melissa-spencer-to-screen-for-calpain-3-targets/2017-05-18T13:11:35+00:00https://curecalpain3.org/rare-disease-stakeholders-connect-at-2017-rare-patient-advocacy-symposium/2017-05-22T19:45:46+00:00https://curecalpain3.org/international-lgmd2a-patient-registry/2017-06-26T18:59:37+00:00https://curecalpain3.org/muscle-membrane-serendipity-conference/2017-08-02T14:57:00+00:00https://curecalpain3.org/c3-awards-research-grant-to-dr-rita-perlingeiro-to-develop-gene-editing-strategy-for-lgmd2a/2017-08-23T16:13:08+00:00https://curecalpain3.org/fda-to-step-up-enforcement-of-stem-cell-clinics/2017-09-07T14:25:04+00:00https://curecalpain3.org/together-we-are-stronger-3rd-annual-limb-girdle-muscular-dystrophy-awareness-day/2017-09-22T19:12:06+00:00https://curecalpain3.org/c3-recognizes-september-30-limb-girdle-muscular-dystrophy-awareness-day-with-research-grant/2017-10-02T17:58:43+00:00https://curecalpain3.org/c3-introduces-new-travel-grant-program-for-calpainopathy-researchers/2017-11-15T20:06:56+00:00https://curecalpain3.org/do-you-have-genetic-confirmation-of-your-lgmd-diagnosis/2023-01-12T16:22:28+00:00https://curecalpain3.org/c3-announces-gene-therapy-initiative/2018-02-27T21:59:29+00:00https://curecalpain3.org/did-you-know-there-are-two-ways-that-calpainopathy-can-be-inherited/2025-12-11T17:41:28+00:00https://curecalpain3.org/c3-gene-therapy-initiative-awards-research-grant-to-dr-isabelle-richard/2018-03-28T17:17:34+00:00https://curecalpain3.org/coalition-to-cure-calpain-3-awards-grant-to-dr-kathryn-wagner/2018-04-24T14:28:08+00:00https://curecalpain3.org/c3-statement-regarding-partnership-between-myonexus-and-sarepta-therapeutics/2018-05-08T20:52:34+00:00https://curecalpain3.org/c3-awards-gene-therapy-initiative-grant-to-dr-zarife-sahenk/2018-06-12T15:33:01+00:00https://curecalpain3.org/limb-girdle-muscular-dystrophy-consortium-forms-to-prepare-for-clinical-trials/2018-07-31T13:17:30+00:00https://curecalpain3.org/together-we-are-stronger-4th-annual-lgmd-awareness-day-is-coming-up/2018-09-17T14:04:50+00:00https://curecalpain3.org/coalition-to-cure-calpain-3-provides-gene-therapy-initiative-updates/2018-09-18T14:47:39+00:00https://curecalpain3.org/c3-presents-at-world-muscle-society-congress/2018-10-09T20:05:28+00:00https://curecalpain3.org/c3-scientific-conference-2018/2018-10-18T20:55:29+00:00https://curecalpain3.org/myonexus-therapeutics-announces-initiation-of-a-gene-therapy-clinical-trial-for-lgmd2e/2018-11-08T21:30:16+00:00https://curecalpain3.org/lgmd2a-patients-sought-for-natural-history-study-at-nationwide-childrens-hospital/2018-11-14T15:13:53+00:00https://curecalpain3.org/save-the-date-national-lgmd-conference-to-be-held-august-30-september-2-2019/2018-11-29T15:49:41+00:00https://curecalpain3.org/c3s-2018-year-in-review/2019-01-02T15:08:53+00:00https://curecalpain3.org/new-report-confirms-calpainopathy-is-most-common-type-of-lgmd/2019-01-16T15:11:51+00:00https://curecalpain3.org/sarepta-therapeutics-announces-preliminary-results-in-clinical-trial-investigating-gene-therapy-for-lgmd2e/2019-02-27T17:52:12+00:00https://curecalpain3.org/c3-awards-research-grant-to-dr-jaakko-sarparanta-to-investigate-relationship-between-calpain-3-activity-and-the-protein-titin/2019-04-02T17:17:06+00:00https://curecalpain3.org/sarepta-therapeutics-adds-lgmd2a-to-their-pipeline/2019-05-08T20:59:30+00:00https://curecalpain3.org/may-20-is-clinical-trials-awareness-day/2019-05-20T14:45:59+00:00https://curecalpain3.org/c3-hosts-gene-therapy-for-lgmd2a-workshop/2019-06-28T18:47:19+00:00https://curecalpain3.org/patients-sought-for-c3-funded-clinical-endpoints-study/2019-07-25T14:05:35+00:00https://curecalpain3.org/dr-stefanie-muthel-awarded-first-early-career-investigator-travel-grant/2019-08-08T14:11:26+00:00https://curecalpain3.org/individuals-with-lgmd-are-sought-for-clinical-trial-evaluating-the-safety-and-efficacy-of-oral-weekly-glucocorticoid-steroids/2019-09-09T18:15:44+00:00https://curecalpain3.org/together-we-are-stronger-5th-annual-lgmd-awareness-day-is-coming-up/2019-09-11T20:42:56+00:00https://curecalpain3.org/published-research-alert-gene-correction-of-lgmd2a-specific-ipscs-for-the-development-of-targeted-autologous-cell-therapy/2019-09-16T14:26:12+00:00https://curecalpain3.org/university-of-florida-college-of-medicine-study-recruiting-lgmd2a-patients-living-in-the-southeast-u-s-and-texas/2019-09-18T14:12:06+00:00https://curecalpain3.org/new-resource-to-learn-about-clinical-research-opportunities-for-lgmd2a/2019-09-25T20:24:02+00:00https://curecalpain3.org/an-lgmd-by-any-other-name-is-still-an-lgmd-new-nomenclature-for-the-lgmds/2019-10-09T20:04:38+00:00https://curecalpain3.org/2019-world-muscle-society-recap/2019-10-15T14:11:51+00:00https://curecalpain3.org/c3-scientific-director-dr-jennifer-levy-appointed-to-muscular-dystrophy-coordinating-committee/2019-11-01T13:25:08+00:00https://curecalpain3.org/double-your-donation-on-giving-tuesday-2019/2019-12-03T13:13:27+00:00https://curecalpain3.org/promising-insights-into-safety-of-lgmd2a-r1-gene-therapy-approach/2019-12-17T13:11:21+00:00https://curecalpain3.org/2019-the-c3-year-in-numbers/2019-12-31T19:35:22+00:00https://curecalpain3.org/plasmid-mediated-gene-therapy-shows-promise-for-lgmd2a-r1-patients/2020-01-13T19:52:06+00:00https://curecalpain3.org/dufour-lab-to-investigate-the-biological-role-of-calpain-3-in-muscle/2020-01-21T18:01:17+00:00https://curecalpain3.org/c3-grant-awardee-featured-in-lgmd-awareness-day-spotlight-interview/2020-02-12T14:27:56+00:00https://curecalpain3.org/join-coalition-to-cure-calpain-3-in-celebrating-rare-disease-day/2020-02-27T20:53:10+00:00https://curecalpain3.org/dr-timothy-dalton-spins-for-a-cure/2020-03-03T19:17:50+00:00https://curecalpain3.org/covid-19-resources-for-the-lgmd2a-r1-community/2020-05-01T14:12:48+00:00https://curecalpain3.org/research-survey-for-rare-disease-patients-and-their-families-about-impacts-of-covid-19/2020-05-15T13:04:14+00:00https://curecalpain3.org/may-20-is-clinical-trials-day/2020-05-20T14:55:40+00:00https://curecalpain3.org/notes-from-23rd-annual-meeting-of-the-american-society-for-gene-and-cell-therapy/2020-05-22T14:18:05+00:00https://curecalpain3.org/attention-healthcare-professionals-virtual-treat-nmd-lgmd-masterclass-to-be-held-september-23-24-2020/2020-06-10T15:45:30+00:00https://curecalpain3.org/care-questionnaire-study-for-the-lgmds-your-help-is-needed/2020-07-14T16:55:56+00:00https://curecalpain3.org/the-6th-annual-lgmd-awareness-day-is-coming-up/2020-09-01T15:21:28+00:00https://curecalpain3.org/patient-recruitment-underway-for-c3-sponsored-natural-history-study/2020-09-11T21:15:36+00:00https://curecalpain3.org/c3-celebrates-a-decade-of-achievement/2020-10-01T12:24:21+00:00https://curecalpain3.org/c3-is-putting-lgmd-on-the-map/2020-10-19T15:42:08+00:00https://curecalpain3.org/c3-is-building-scientific-leadership/2020-10-13T11:40:00+00:00https://curecalpain3.org/c3-is-connecting-patients-with-one-another/2020-10-20T12:20:40+00:00https://curecalpain3.org/promising-study-identifies-compound-that-improves-muscle-in-lgmd2a-r1-mice/2020-10-23T18:23:11+00:00https://curecalpain3.org/building-the-first-lgmd2a-r1-patient-registry/2020-10-27T11:25:19+00:00https://curecalpain3.org/c3-is-connecting-patients-to-clinical-studies/2020-11-03T13:00:32+00:00https://curecalpain3.org/c3-is-increasing-scientific-collaboration-to-fight-lgmd2a-r1/2020-11-10T12:37:41+00:00https://curecalpain3.org/fda-patient-listening-session-on-lgmds-held-october-20-2020/2020-11-16T15:28:39+00:00https://curecalpain3.org/c3-is-expanding-the-field-of-lgmd2a-r1-researchers/2020-11-16T15:42:14+00:00https://curecalpain3.org/c3-is-driving-progress-towards-a-cutting-edge-cure/2020-11-23T19:23:21+00:00https://curecalpain3.org/c3-is-poised-to-make-a-difference-in-the-next-ten-years-and-beyond/2020-11-30T20:19:18+00:00https://curecalpain3.org/organizations-team-up-to-urge-health-officials-to-prioritize-the-neuromuscular-disease-community-for-covid-19-vaccine-access/2020-12-16T22:09:11+00:00https://curecalpain3.org/lgmd2a-r1-patient-enrollment-underway-for-c3-sponsored-natural-history-study/2021-01-18T18:29:13+00:00https://curecalpain3.org/lgmd2a-r1-participants-sought-for-covid-19-survey/2021-02-09T12:42:09+00:00https://curecalpain3.org/c3-selected-as-platinum-member-of-the-national-organization-for-rare-diseases/2021-04-02T13:05:32+00:00https://curecalpain3.org/c3-awards-research-grant-to-drs-melissa-spencer-and-jeffrey-chamberlain-to-develop-gene-therapy-vectors-for-lgmd2a-r1/2021-04-12T18:39:15+00:00https://curecalpain3.org/help-us-make-a-big-change-for-the-lgmd-community/2021-04-19T20:49:33+00:00https://curecalpain3.org/will-you-help-advance-lgmd2a-r1-research-by-participating-in-the-grasp-lgmd-natural-history-study/2022-01-11T18:40:26+00:00https://curecalpain3.org/new-publication-illuminates-the-effects-of-the-covid-19-pandemic-on-people-with-muscular-dystrophy/2021-06-14T18:40:08+00:00https://curecalpain3.org/published-research-alert-capn3-gene-therapy-improves-muscles-function-in-a-mouse-model-of-limb-girdle-muscular-dystrophy-type-2a-r1-lgmd2a-r1/2021-07-16T20:47:30+00:00https://curecalpain3.org/funding-opportunity-coalition-to-cure-calpain-3-issues-request-for-applications-for-research-related-to-lgmd2a-r1/2021-07-22T17:45:03+00:00https://curecalpain3.org/sarepta-announces-gene-therapy-program-for-lgmd2a-r1/2021-08-04T15:21:29+00:00https://curecalpain3.org/register-now-for-the-2021-international-lgmd-conference/2021-08-16T15:55:52+00:00https://curecalpain3.org/together-we-are-stronger-7th-annual-lgmd-awareness-day-is-coming-up/2021-09-13T13:06:05+00:00https://curecalpain3.org/a-special-message-from-lionel-messi-to-the-c3-community/2021-09-21T19:31:23+00:00https://curecalpain3.org/carol-abraham-appointed-to-patient-engagement-collaborative/2021-11-18T19:28:39+00:00https://curecalpain3.org/c3-to-participate-in-externally-led-pfdd-meeting-with-fda/2021-12-06T13:58:34+00:00https://curecalpain3.org/whats-on-the-horizon-for-lgmd2a-r1/2022-01-11T16:17:01+00:00https://curecalpain3.org/have-you-participated-in-a-clinical-research-study/2022-02-15T16:21:12+00:00https://curecalpain3.org/join-coalition-to-cure-calpain-3-in-celebrating-rare-disease-day-2/2022-02-28T15:41:55+00:00https://curecalpain3.org/daniel-ferguson-lgmd-foundation-launches/2022-03-01T13:35:39+00:00https://curecalpain3.org/sarepta-therapeutics-q1-update-on-lgmd-programs/2022-03-03T20:10:36+00:00https://curecalpain3.org/do-you-have-questions-about-lgmd2a-r1/2022-03-22T18:44:02+00:00https://curecalpain3.org/lgmd-diagnostic-codes-proposed-for-final-implementation/2022-04-21T12:44:09+00:00https://curecalpain3.org/c3-awards-grant-to-university-of-florida-researchers-to-investigate-calcium-handling-in-lgmd2a-r1/2022-04-26T11:26:49+00:00https://curecalpain3.org/c3-funds-development-of-new-lgmd2a-r1-disease-model-for-preclinical-testing/2022-05-12T20:30:06+00:00https://curecalpain3.org/its-official-the-lgmd-community-celebrates-adoption-of-icd-10-diagnostic-codes-for-lgmd/2022-06-30T12:45:52+00:00https://curecalpain3.org/limb-girdle-muscular-dystrophy-coalition-to-host-externally-led-patient-focused-drug-development-meeting/2022-07-05T18:07:18+00:00https://curecalpain3.org/pre-registration-is-now-open-for-the-lgmd-el-pfdd-meeting-with-fda-and-other-stakeholders/2022-07-20T17:31:31+00:00https://curecalpain3.org/casimir-recruiting-lgmd2a-r1-patients-for-at-home-study/2022-08-22T12:23:37+00:00https://curecalpain3.org/together-we-are-stronger-8th-annual-lgmd-awareness-day-is-coming-up/2022-08-30T15:39:24+00:00https://curecalpain3.org/the-lgmd-el-pfdd-is-just-one-week-away/2022-09-16T14:30:59+00:00https://curecalpain3.org/your-voice-made-a-difference/2022-09-27T15:04:50+00:00https://curecalpain3.org/new-lgmd2a-r1-mice-novel-tools-for-drug-development/2022-11-10T21:09:33+00:00https://curecalpain3.org/our-giving-tuesday-fundraiser-starts-now/2022-11-22T15:57:51+00:00https://curecalpain3.org/travel-grant-program-for-early-career-investigators/2022-12-02T12:33:38+00:00https://curecalpain3.org/c3-partners-with-16-lgmd-organizations-in-letter-to-fda/2022-12-19T21:00:50+00:00https://curecalpain3.org/c3s-countdown-to-the-new-year/2022-12-27T19:59:39+00:00https://curecalpain3.org/new-research-grant-aims-to-improve-genetic-diagnoses-in-individuals-with-capn3-mutations/2023-02-09T19:31:30+00:00https://curecalpain3.org/sarepta-community-update-on-lgmd-programs/2023-02-17T18:07:40+00:00https://curecalpain3.org/join-coalition-to-cure-calpain-3-in-celebrating-rare-disease-day-3/2023-02-27T12:55:20+00:00https://curecalpain3.org/publication-shares-development-of-new-animal-model-of-lgmd2a-r1/2023-03-02T12:50:37+00:00https://curecalpain3.org/c3-funds-retrospective-analysis-of-clinical-outcome-assessments/2023-05-01T12:53:00+00:00https://curecalpain3.org/new-voice-of-the-patient-report-highlights-unmet-medical-needs-of-six-subtypes-of-lgmd-including-lgmd2a-r1/2023-05-15T13:08:04+00:00https://curecalpain3.org/may-20-is-clinical-trials-day-2/2023-05-19T19:08:24+00:00https://curecalpain3.org/vita-therapeutics-enters-licensing-agreement-with-milliporesigma/2023-07-18T14:52:39+00:00https://curecalpain3.org/coalition-to-cure-calpain-3-in-partnership-with-the-national-organization-forrare-disorders-nord-launches-lgmd2a-calpainopathy-registry/2023-09-21T16:23:40+00:00https://curecalpain3.org/dr-stephanie-hunn-awarded-c3-travel-grant/2023-10-10T16:59:23+00:00https://curecalpain3.org/genetic-testing-for-lgmds/2024-12-09T13:09:18+00:00https://curecalpain3.org/new-lgmd2a-r1-mouse-model-available-at-jackson-labs/2023-12-01T18:48:17+00:00https://curecalpain3.org/know-your-code-why-the-new-icd-10-codes-matter-and-what-you-can-do-to-confirm-your-records/2024-01-09T21:25:01+00:00https://curecalpain3.org/countdown-to-the-new-year-2023-edition/2023-12-29T13:47:57+00:00https://curecalpain3.org/trial-readiness-study-for-individuals-with-lgmd2a-r1/2024-01-25T18:14:19+00:00https://curecalpain3.org/c3-attends-the-2024-mda-clinical-and-scientific-conference/2024-03-08T14:07:13+00:00https://curecalpain3.org/c3-hosts-sarepta-to-present-webinar-about-the-journey-natural-history-study/2024-03-16T18:05:14+00:00https://curecalpain3.org/volker-straub-appointed-to-c3-scientific-advisory-board/2024-04-10T19:34:13+00:00https://curecalpain3.org/watch-sarepta-presents-webinar-about-new-natural-history-study-for-individuals-living-with-lgmd2a-r1/2024-04-17T21:29:23+00:00https://curecalpain3.org/vita-therapeutics-letter-to-the-lgmd2a-r1-community/2024-04-22T18:22:28+00:00https://curecalpain3.org/new-natural-history-study-recruiting-individuals-with-lgmd2a-r1-in-france/2024-05-16T20:09:21+00:00https://curecalpain3.org/sarepta-therapeutics-recruits-for-clinical-outcomes-assessment-study/2024-06-07T12:16:57+00:00https://curecalpain3.org/published-research-alert-atypical-calcium-handling-in-muscles-of-mouse-model-of-lgmd2a-r1/2024-07-26T16:56:04+00:00https://curecalpain3.org/c3-celebrates-10th-annual-lgmd-awareness-day/2024-09-30T12:40:08+00:00https://curecalpain3.org/c3-joins-task-force-to-advance-therapeutic-development-for-limb-girdle-muscular-dystrophies/2024-09-30T16:35:20+00:00https://curecalpain3.org/what-can-you-do-to-drive-lgmd2a-r1-research-forward-participate-in-a-natural-history-study/2025-11-10T19:50:57+00:00https://curecalpain3.org/c3-announces-request-for-applications-for-research-into-calpainopathy/2024-11-05T13:44:47+00:00https://curecalpain3.org/c3-scientific-meeting-recap/2024-11-11T17:27:41+00:00https://curecalpain3.org/upcoming-webinar-the-power-of-data-sharing-and-collaboration-across-lgmds-in-a-pre-competitive-neutral-environment/2024-12-02T16:22:56+00:00https://curecalpain3.org/coalition-to-cure-calpain-3-and-muscular-dystrophy-association-partner-to-fund-gene-therapy-grant/2024-12-17T14:20:51+00:00https://curecalpain3.org/2024-marked-by-collaboration-community-commitment/2024-12-28T13:06:42+00:00https://curecalpain3.org/sarepta-therapeutics-update/2025-02-27T16:01:08+00:00https://curecalpain3.org/c3-celebrates-rare-disease-day/2025-02-28T22:14:00+00:00https://curecalpain3.org/sarepta-community-update-on-lgmd-programs-2/2025-04-15T15:12:56+00:00https://curecalpain3.org/upcoming-event-international-lgmd-conference/2025-04-18T16:52:21+00:00https://curecalpain3.org/new-research-alert-grasp-001-study/2025-04-22T12:31:03+00:00https://curecalpain3.org/community-health-clinic-publishes-newsletter-focused-on-lgmds/2025-05-16T11:56:38+00:00https://curecalpain3.org/lgmd2a-r1-standards-of-care-workshop/2025-07-30T20:11:35+00:00https://curecalpain3.org/c3-attends-the-2025-international-lgmd-conference/2025-07-30T19:56:17+00:00https://curecalpain3.org/whats-new-in-lgmd2a-r1-research-posters-highlight-new-research-at-the-international-lgmd-conference/2025-08-15T15:20:23+00:00https://curecalpain3.org/new-publication-characterizes-mouse-model-of-calpainopathy/2025-11-03T14:16:10+00:00https://curecalpain3.org/new-research-alert-measuring-motor-function-in-lgmd2a-r1/2025-11-10T13:21:48+00:00https://curecalpain3.org/double-the-impact-of-your-giving-tuesday-donation/2025-11-18T15:56:21+00:00https://curecalpain3.org/giving-tuesday-2025-meet-matt/2025-12-01T12:58:01+00:00https://curecalpain3.org/giving-tuesday-2025-meet-charley/2025-11-25T22:44:21+00:00https://curecalpain3.org/giving-tuesday-2025-meet-dani/2025-11-25T22:44:09+00:00https://curecalpain3.org/giving-tuesday-2025-meet-courtney/2025-11-25T22:43:58+00:00https://curecalpain3.org/giving-tuesday-meet-noni-and-maria/2025-11-25T22:43:46+00:00https://curecalpain3.org/new-research-grant-multi-national-collaboration-aims-to-identify-biomarkers/2025-11-25T13:12:12+00:00https://curecalpain3.org/giving-tuesday-2025-meet-daniel/2025-11-25T22:43:32+00:00https://curecalpain3.org/giving-tuesday-2025-meet-reagan/2025-11-25T22:43:16+00:00https://curecalpain3.org/giving-tuesday-2025-meet-andy/2025-11-25T22:42:57+00:00https://curecalpain3.org/giving-tuesday-2025-meet-walker/2025-11-25T22:59:02+00:00https://curecalpain3.org/giving-tuesday-2025-meet-rexton/2025-11-25T22:58:37+00:00https://curecalpain3.org/giving-tuesday-2025-meet-bec/2025-11-25T22:59:24+00:00https://curecalpain3.org/giving-tuesday-2025-meet-brooklyn/2025-11-25T22:58:10+00:00https://curecalpain3.org/new-research-grant-investigating-calcium-handling-modulation-as-a-potential-therapeutic-for-lgmd2a-r1/2025-12-03T20:38:42+00:00https://curecalpain3.org/new-research-grant-aims-to-improve-genetic-diagnostics-in-individuals-with-capn3-mutations/2025-12-10T13:10:37+00:00https://curecalpain3.org/new-year-new-chair-c3-welcomes-melina-garza-to-new-role-as-advocacy-chair/2026-01-07T18:36:07+00:00https://curecalpain3.org/new-research-grant-solving-the-structure-of-calpain-3/2026-01-21T20:48:16+00:00https://curecalpain3.org/travel-grant-program-for-early-career-investigators-2/2026-01-28T22:07:25+00:00https://curecalpain3.org/grasp-01-003-natural-history-study-is-recruiting-now-through-april-30/2026-02-26T21:42:12+00:00https://curecalpain3.org/new-research-alert-expert-consortium-publishes-lgmd2a-r1-longitudinal-data/2026-04-15T17:23:04+00:00https://curecalpain3.org/dr-melissa-spencer-provides-update-on-development-of-an-lgmd2a-r1-gene-therapy/2026-04-17T12:15:42+00:00https://curecalpain3.org/the-speak-foundation-launches-national-lgmd-centers-of-excellence/2026-04-21T14:42:02+00:00https://curecalpain3.org/meet-c3-at-two-upcoming-engage-events-hosted-by-the-mda/2026-06-04T22:41:30+00:00https://curecalpain3.org/new-research-grant-aims-to-improve-understanding-of-dominant-calpainopathy/2026-07-13T18:03:55+00:00